4.5 Article

Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide

期刊

FEBS LETTERS
卷 581, 期 28, 页码 5440-5444

出版社

WILEY
DOI: 10.1016/j.febslet.2007.10.046

关键词

breast cancer; chemotherapy resistance; tumor development; tumor suppressor; apoptosis

资金

  1. NCI NIH HHS [R01 CA076406, CA 76406, R01 CA101992, CA 112102, CA 101992, R01 CA076406-05S1, R01 CA112102] Funding Source: Medline

向作者/读者索取更多资源

Expression of p53-target gene EI24/PIG8 is lost in invasive breast cancers, suggesting that EI24/PIG8 is a tumor suppressor that prevents tumor spreading, and partially mediates p53-attributed tumor suppressor activity. EI24/PIG8 also has pro-apoptotic activity indicating that loss of EI24/PIG8 may modulate sensitivity to chemotherapy. Here it is demonstrated that suppression of EI24/PIG8 in fibroblasts and breast cancer cells significantly inhibits the apoptotic response to etoposide treatment. These findings suggest that loss of EI24/PIG8 contributes significantly to resistance of cells to chemotherapeutic agents that function through p53, and identify the EI24/PIG8 status as a potentially new prognostic marker of chemotherapy responsiveness. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据